Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Clinical evaluation of a live attenuated Respiratory Syncytial Virus (RSV) vaccine based on a genetically modified RSV virus lacking the coding sequence for the attachment protein G

Proposed period of release:
16/04/2018 to 31/12/2030

Name of the Institute(s) or Company(ies)
Centre of Human Drug Research, Zernikedreef 8
2333 CL Leiden;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Pneumovirus, Respiratory Syncytial virus A

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Human Respiratory Syncytial virusOrthopneumovirusHuman Respiratory Syncytial virusSubtype AClinical isolate RSV 98-25147-Xgenotype GA2

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known